‘In­ac­cu­ra­cies’ push FDA to re­verse Trump-era ter­mi­na­tion of its Un­ap­proved Drugs Ini­tia­tive

Due to “mul­ti­ple le­gal and fac­tu­al in­ac­cu­ra­cies,” the Biden ad­min­is­tra­tion’s FDA said Wednes­day that it will re­verse the Trump-era de­ci­sion to pull the agency’s con­tro­ver­sial …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER